Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2009

01.10.2009 | Article

Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital

verfasst von: M. M. L. van Rijen, J. A. J. W. Kluytmans

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to determine the costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital during 2001 through 2006. Variable costs included costs for isolation, contact tracing, treatment of carriers and closure of wards. Fixed costs were the costs for the building of isolation rooms and the salary of one full-time infection control practitioner. To determine the benefits of the Search and Destroy policy, the transmission rate during the study period was calculated. Furthermore, the number of cases of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia prevented was estimated, as well as its associated prevented costs and patient lives. The costs of the MRSA policy were estimated to be €215,559 a year, which equals €5.54 per admission. The daily isolation costs for MRSA-suspected and -positive hospitalised patients were €95.59 and €436.62, respectively. Application of the Search and Destroy policy resulted in a transmission rate of 0.30 and was estimated to prevent 36 cases of MRSA bacteraemia per year, resulting in annual savings of €427,356 for the hospital and ten lives per year (95% confidence interval [CI] 8–14). In conclusion, application of the MRSA Search and Destroy policy in a hospital in a country with a low endemic MRSA incidence saves money and lives.
Literatur
1.
Zurück zum Zitat Kluytmans-VandenBergh MFQ, Kluytmans JAJW (2006) Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 12(Suppl 1):9–15PubMedCrossRef Kluytmans-VandenBergh MFQ, Kluytmans JAJW (2006) Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clin Microbiol Infect 12(Suppl 1):9–15PubMedCrossRef
2.
Zurück zum Zitat Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JCM, Grundmann H (2005) Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 11:1798–1799PubMed Tiemersma EW, Monnet DL, Bruinsma N, Skov R, Monen JCM, Grundmann H (2005) Staphylococcus aureus bacteremia, Europe. Emerg Infect Dis 11:1798–1799PubMed
4.
Zurück zum Zitat van Rijen MML, Van Keulen PH, Kluytmans JAJW (2008) Increase in a Dutch hospital of methicillin-resistant Staphylococcus aureus related to animal farming. Clin Infect Dis 46(2):261–263PubMedCrossRef van Rijen MML, Van Keulen PH, Kluytmans JAJW (2008) Increase in a Dutch hospital of methicillin-resistant Staphylococcus aureus related to animal farming. Clin Infect Dis 46(2):261–263PubMedCrossRef
5.
Zurück zum Zitat van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J (2007) Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 13:1834–1839PubMed van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, Voss A, Kluytmans J (2007) Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 13:1834–1839PubMed
6.
Zurück zum Zitat Wertheim HF, Ammerlaan HS, Bonten MJ, van den Broek PJ, Troelstra A, Vandenbroucke-Grauls CM, Vos MC, Voss A, Nouwen JL, Kluytmans JA (2008) Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers. Ned Tijdschr Geneeskd 152(49):2667–2671PubMed Wertheim HF, Ammerlaan HS, Bonten MJ, van den Broek PJ, Troelstra A, Vandenbroucke-Grauls CM, Vos MC, Voss A, Nouwen JL, Kluytmans JA (2008) Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers. Ned Tijdschr Geneeskd 152(49):2667–2671PubMed
7.
Zurück zum Zitat Vriens M, Blok H, Fluit A, Troelstra A, van der Werken C, Verhoef J (2002) Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch university medical center: a 10-year survey. Eur J Clin Microbiol Infect Dis 21:782–786PubMedCrossRef Vriens M, Blok H, Fluit A, Troelstra A, van der Werken C, Verhoef J (2002) Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch university medical center: a 10-year survey. Eur J Clin Microbiol Infect Dis 21:782–786PubMedCrossRef
8.
Zurück zum Zitat Nulens E, Broex E, Ament A, Deurenberg RH, Smeets E, Scheres J, van Tiel FH, Gordts B, Stobberingh EE (2008) Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital. J Hosp Infect 68(4):301–307PubMedCrossRef Nulens E, Broex E, Ament A, Deurenberg RH, Smeets E, Scheres J, van Tiel FH, Gordts B, Stobberingh EE (2008) Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital. J Hosp Infect 68(4):301–307PubMedCrossRef
9.
Zurück zum Zitat Griffiths C, Lamagni TL, Crowcroft NS, Duckworth G, Rooney C (2004) Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993–2002. Health Stat Q 21:15–22PubMed Griffiths C, Lamagni TL, Crowcroft NS, Duckworth G, Rooney C (2004) Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993–2002. Health Stat Q 21:15–22PubMed
10.
Zurück zum Zitat Wyllie DH, Crook DW, Peto TEA (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 333(7562):281PubMedCrossRef Wyllie DH, Crook DW, Peto TEA (2006) Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997–2003: cohort study. BMJ 333(7562):281PubMedCrossRef
11.
Zurück zum Zitat Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26(2):166–174PubMedCrossRef Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y (2005) The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 26(2):166–174PubMedCrossRef
12.
Zurück zum Zitat Bootsma MC, Diekmann O, Bonten MJ (2006) Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 103(14):5620–5625PubMedCrossRef Bootsma MC, Diekmann O, Bonten MJ (2006) Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci USA 103(14):5620–5625PubMedCrossRef
13.
Zurück zum Zitat Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59PubMedCrossRef Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59PubMedCrossRef
14.
Zurück zum Zitat Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771PubMedCrossRef Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK; Active Bacterial Core surveillance (ABCs) MRSA Investigators (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763–1771PubMedCrossRef
Metadaten
Titel
Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital
verfasst von
M. M. L. van Rijen
J. A. J. W. Kluytmans
Publikationsdatum
01.10.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0775-8

Weitere Artikel der Ausgabe 10/2009

European Journal of Clinical Microbiology & Infectious Diseases 10/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.